<VariationArchive VariationID="3101" VariationName="NM_005670.4(EPM2A):c.335dup (p.Tyr112Ter)" VariationType="Duplication" Accession="VCV000003101" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18140" VariationID="3101">
      <GeneList>
        <Gene Symbol="EPM2A" FullName="EPM2A glucan phosphatase, laforin" GeneID="7957" HGNC_ID="HGNC:3413" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145383353" stop="145736023" display_start="145383353" display_stop="145736023" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="145946439" stop="146056990" display_start="145946439" display_stop="146056990" Strand="-" />
          </Location>
          <OMIM>607566</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005670.4(EPM2A):c.335dup (p.Tyr112Ter)</Name>
      <CanonicalSPDI>NC_000006.12:145686262:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145686262" stop="145686263" display_start="145686262" display_stop="145686263" variantLength="1" positionVCF="145686262" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="146007398" stop="146007399" display_start="146007398" display_stop="146007399" variantLength="1" positionVCF="146007398" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>Y112*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.146007399dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.146007399dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.145686263dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.145686263dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012832.2" sequenceAccession="NG_012832" sequenceVersion="2" change="g.54593dup">
            <Expression>NG_012832.2:g.54593dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018041.2" sequenceAccession="NM_001018041" sequenceVersion="2" change="c.335dup">
            <Expression>NM_001018041.2:c.335dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018051.1" sequenceAccession="NP_001018051" sequenceVersion="1" change="p.Tyr112Ter">
            <Expression>NP_001018051.1:p.Tyr112Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360057.2" sequenceAccession="NM_001360057" sequenceVersion="2" change="c.335dup">
            <Expression>NM_001360057.2:c.335dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001346986.1" sequenceAccession="NP_001346986" sequenceVersion="1" change="p.Tyr112Ter">
            <Expression>NP_001346986.1:p.Tyr112Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360064.2" sequenceAccession="NM_001360064" sequenceVersion="2" change="c.-80dup">
            <Expression>NM_001360064.2:c.-80dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360071.2" sequenceAccession="NM_001360071" sequenceVersion="2" change="c.-80dup">
            <Expression>NM_001360071.2:c.-80dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368129.2" sequenceAccession="NM_001368129" sequenceVersion="2" change="c.-289dup">
            <Expression>NM_001368129.2:c.-289dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368130.1" sequenceAccession="NM_001368130" sequenceVersion="1" change="c.335dup">
            <Expression>NM_001368130.1:c.335dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355059.1" sequenceAccession="NP_001355059" sequenceVersion="1" change="p.Tyr112Ter">
            <Expression>NP_001355059.1:p.Tyr112Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368131.1" sequenceAccession="NM_001368131" sequenceVersion="1" change="c.-80dup">
            <Expression>NM_001368131.1:c.-80dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368132.1" sequenceAccession="NM_001368132" sequenceVersion="1" change="c.-289dup">
            <Expression>NM_001368132.1:c.-289dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005670.4" sequenceAccession="NM_005670" sequenceVersion="4" change="c.335dup" MANESelect="true">
            <Expression>NM_005670.4:c.335dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005661.1" sequenceAccession="NP_005661" sequenceVersion="1" change="p.Tyr112Ter">
            <Expression>NP_005661.1:p.Tyr112Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_153398.2" sequenceAccession="NR_153398" sequenceVersion="2" change="n.150dup">
            <Expression>NR_153398.2:n.150dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252545" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607566.0004" DB="OMIM" />
        <XRef Type="rs" ID="587776553" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9931343, and determined the affected amino acid residue to be Tyr112 in NP_005661.1.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005670.4(EPM2A):c.335dup (p.Tyr112Ter) AND Myoclonic epilepsy of Lafora 1" Accession="RCV004576873" Version="1">
        <ClassifiedConditionList TraitSetID="96298">
          <ClassifiedCondition DB="MedGen" ID="C5848203">Myoclonic epilepsy of Lafora 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2005-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16134145</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9931343</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="96298" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="73290" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic epilepsy of Lafora 1</ElementValue>
                <XRef ID="MONDO:0958199" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LAFORA DISEASE 1</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, PROGRESSIVE MYOCLONIC, 2A</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MELF1</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPM2A</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301563</ID>
                <ID Source="BookShelf">NBK1389</ID>
              </Citation>
              <XRef ID="C5848203" DB="MedGen" />
              <XRef ID="MONDO:0958199" DB="MONDO" />
              <XRef Type="MIM" ID="254780" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23405" SubmissionDate="2016-08-04" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607566.0004_EPILEPSY, PROGRESSIVE MYOCLONIC, 2A" title="EPM2A, 1-BP INS, 335A_EPILEPSY, PROGRESSIVE MYOCLONIC, 2A" />
        <ClinVarAccession Accession="SCV000023405" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Ianzano et al. (2005) stated that a 1-bp insertion in exon 2 of the EPM2A gene (335_336insA), resulting in a frameshift and premature termination (Tyr112fs), had been identified in 2 unrelated families with Lafora progressive myoclonic epilepsy (EPM2A; 254780). They noted that one of the families had been reported by Serratosa et al. (1999). In the report by Serratosa et al. (1999), a family (S114) with Lafora-type myoclonic epilepsy was found to have an insertion of an adenine after nucleotide 94 of the EPM2A cDNA (94_95insA), causing a frameshift and truncation of the gene product after tyr31.</Attribute>
              <Citation>
                <ID Source="PubMed">16134145</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9931343</ID>
              </Citation>
              <XRef DB="OMIM" ID="254780" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPM2A" />
          </GeneList>
          <Name>EPM2A, 1-BP INS, 335A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 335A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607566.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPILEPSY, PROGRESSIVE MYOCLONIC, 2A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23405" TraitType="Disease" MappingType="Name" MappingValue="EPILEPSY, PROGRESSIVE MYOCLONIC, 2A" MappingRef="Preferred">
        <MedGen CUI="C5848203" Name="Myoclonic epilepsy of Lafora 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

